BGC > Produktsuche > Biotin-Ahx-Ahx-Tyramide | 851113-28-5

Description:
The thieno[3,4-d]imidazol-4-yl moiety embedded within this newly synthesized compound harbors the potential for therapeutic utility against neurological disorders. However, its intricate structure demands rigorous evaluation of its safety and efficacy as a potential drug prior to clinical translation. Despite preliminary implications, extensive studies are necessary to determine the full scope of its therapeutic potential.

• Molecular Weight:589.8

Molecular Formula:
C30H47N5O5S
Canonical SMILES:
C1C2C(C(S1)CCCCC(=O)NCCCCCC(=O)NCCCCCC(=O)NCCC3=CC=C(C=C3)O)NC(=O)N2
InChI:
InChI=1S/C30H47N5O5S/c36-23-15-13-22(14-16-23)17-20-33-28(39)11-4-2-8-18-31-26(37)10-3-1-7-19-32-27(38)12-6-5-9-25-29-24(21-41-25)34-30(40)35-29/h13-16,24-25,29,36H,1-12,17-21H2,(H,31,37)(H,32,38)(H,33,39)(H2,34,35,40)/t24-,25-,29-/m0/s1
InChIKey:
AONIROLXOSTVPV-QEMZJVQQSA-N
Synonyms:
N-(4-Hydroxyphenethyl)-6-(6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)hexanamide; Biotin-Ahx-Ahx-Tyramide

Formula:
C30H47N5O5S
Mol Weight:
589,8g/mol
Synonym:
Biotin-XX-Phenol, N-(4-hydroxyphenethyl)-6-(6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)hexanamide